FIELD: medicine.
SUBSTANCE: present invention relates to novel condensed pyrimidine derivative of formula (I) or its pharmaceutically acceptable salt. In compounds of formula (I)
W represents S; X represents O, NH, S, SO or SO2; Y denotes hydrogen atom, halogen atom, C1-6alkyl or C1-6alkoxy; each of A and B independently denotes hydrogen atom, halogen atom or di(C1-6alkyl)aminomethyl; where optionally C1-6alkyl is partially unsaturated or contains C3-6cycloalkyl fragment, Z is selected from group consisting of formulae Z1-Z203. Formulae Z1-Z203 are given in paragraph 1 of patent claim.
EFFECT: compounds can be used for preparing drug for preventing or treating cancer, tumour, inflammatory diseases mediated by at least one kinase, selected from a group consisting of Bruton tyrosine kinase (BTK), Janus Kinase 3 (JAK3) induced interleukin-2 T-cell kinase (ITK), kinase resting lymphocytes (RLK) and tyrosine kinase bone marrow (BMX).
18 cl, 3 dwg, 19 tbl, 247 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NOVEL FUSED PYRIMIDINE DERIVATIVES FOR INHIBITION OF TYROSINE KINASE ACTIVITY | 2011 |
|
RU2598852C2 |
| NOVEL AMIDE DERIVATIVE FOR INHIBITING GROWTH OF CANCER CELLS | 2008 |
|
RU2434010C2 |
| QUINAZOLINE DERIVATIVES FOR SLOWING DOWN GROWTH OF CANCER CELLS AND METHOD OF OBTAINING THEM | 2005 |
|
RU2362773C2 |
| HETEROCYCLIC DERIVATIVES AND USE THEREOF | 2014 |
|
RU2681849C2 |
| THIENO[3,2-d]PYRIMIDINE DERIVATIVES, POSSESSING INHIBITING ACTION WITH RESPECT TO PROTEINKINASE | 2011 |
|
RU2524210C2 |
| NOVEL IMIDAZOLE DERIVATIVE HAVING JNK INHIBITORY ACTIVITY, AND USE THEREOF | 2017 |
|
RU2702749C1 |
| NOVEL COMPOUNDS, ISOMERS THEREOF OR PHARMACUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONISTS AND PHARMACEUTICAL COMPOSITION CONTAINING SAID COMPOUNDS | 2007 |
|
RU2448108C2 |
| 2-PYRIDYL SUBSTITUTED IMIDAZOLES AS ALK5 AND/OR ALK4 INHIBITORS | 2012 |
|
RU2612958C2 |
| AZAADAMANTANE DERIVATIVES AND METHODS FOR APPLYING | 2007 |
|
RU2450002C2 |
| THIENO[3,2-d]PYRIMIDINE DERIVATIVES WITH PROTEIN KINASE INHIBITORY ACTIVITY | 2012 |
|
RU2705577C2 |
